825 related articles for article (PubMed ID: 36198236)
21. Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village.
Ao YQ; Gao J; Jiang JH; Wang HK; Wang S; Ding JY
Mol Ther; 2023 Dec; 31(12):3389-3413. PubMed ID: 37740493
[TBL] [Abstract][Full Text] [Related]
22. Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA.
Ahmadpour ST; Orre C; Bertevello PS; Mirebeau-Prunier D; Dumas JF; Desquiret-Dumas V
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958880
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer.
Li D; Weng S; Zeng K; Xu H; Wang W; Shi J; Chen J; Chen C
Gene; 2024 Feb; 895():148007. PubMed ID: 37981080
[TBL] [Abstract][Full Text] [Related]
24. Recent progress and the emerging role of lncRNAs in cancer drug resistance; focusing on signaling pathways.
Saadh MJ; Rasulova I; Almoyad MAA; Kiasari BA; Ali RT; Rasheed T; Faisal A; Hussain F; Jawad MJ; Hani T; Sârbu I; Lakshmaiya N; Ciongradi CI
Pathol Res Pract; 2024 Jan; 253():154999. PubMed ID: 38118218
[TBL] [Abstract][Full Text] [Related]
25. Targeting long non-coding RNAs in cancers: progress and prospects.
Li CH; Chen Y
Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
[TBL] [Abstract][Full Text] [Related]
26. Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers.
Zabeti Touchaei A; Vahidi S; Samadani AA
Clin Exp Med; 2024 Jan; 24(1):29. PubMed ID: 38294554
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNAs in anti-cancer drug resistance.
Chen QN; Wei CC; Wang ZX; Sun M
Oncotarget; 2017 Jan; 8(1):1925-1936. PubMed ID: 27713133
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNAs and endometrial cancer.
Liu H; Wan J; Chu J
Biomed Pharmacother; 2019 Nov; 119():109396. PubMed ID: 31505425
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
[TBL] [Abstract][Full Text] [Related]
31. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
32. The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity.
Cao MX; Jiang YP; Tang YL; Liang XH
Oncotarget; 2017 Feb; 8(7):12472-12483. PubMed ID: 27992370
[TBL] [Abstract][Full Text] [Related]
33. The functional role of long non-coding RNAs and their underlying mechanisms in drug resistance of non-small cell lung cancer.
Zhou H; Feng B; Abudoureyimu M; Lai Y; Lin X; Tian C; Huang G; Chu X; Wang R
Life Sci; 2020 Nov; 261():118362. PubMed ID: 32871184
[TBL] [Abstract][Full Text] [Related]
34. Lnc-ing epigenetic mechanisms with autophagy and cancer drug resistance.
Nandi S; Mondal A; Ghosh A; Mukherjee S; Das C
Adv Cancer Res; 2023; 160():133-203. PubMed ID: 37704287
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
36. The emerging role of lncRNAs in the regulation of cancer stem cells.
Castro-Oropeza R; Melendez-Zajgla J; Maldonado V; Vazquez-Santillan K
Cell Oncol (Dordr); 2018 Dec; 41(6):585-603. PubMed ID: 30218296
[TBL] [Abstract][Full Text] [Related]
37. Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer.
Yamaguchi K; Yamamoto T; Chikuda J; Shirota T; Yamamoto Y
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204785
[TBL] [Abstract][Full Text] [Related]
38. lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways.
Saleh RO; Al-Ouqaili MTS; Ali E; Alhajlah S; Kareem AH; Shakir MN; Alasheqi MQ; Mustafa YF; Alawadi A; Alsaalamy A
Med Oncol; 2024 Jan; 41(2):52. PubMed ID: 38195957
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNAs: From disease code to drug role.
Chen Y; Li Z; Chen X; Zhang S
Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNAs (lncRNAs) in pancreatic cancer progression.
Ashrafizadeh M; Rabiee N; Kumar AP; Sethi G; Zarrabi A; Wang Y
Drug Discov Today; 2022 Aug; 27(8):2181-2198. PubMed ID: 35589014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
